Magnesium, the Novel Member of the CKD-MBD Family
View More View Less
  • 1 Department of Nephrology and Amsterdam Cardiovascular Sciences, Amsterdam UMC Amsterdam, The Netherlands
  • 1.

    Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, .; Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69: 19451953, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, .; CKD-MBD Working Group of ERA-EDTA: Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? Nephrol Dial Transplant 29: 18151820, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Major RW, Cheng MRI, Grant RA, Shantikumar S, Xu G, Oozeerally I, : Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One 13: e0192895, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, .; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 17771782, 2002 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Feldreich T, Nowak C, Carlsson AC, Östgren CJ, Nyström FH, Sundström J, : The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease. Atherosclerosis 307: 1115, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Malhotra R, Mauer AC, Lino Cardenas CL, Guo X, Yao J, Zhang X, : HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat Genet 51: 15801587, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Ärnlöv J, Dluzen DF, Nowak C: Atherosclerotic aortic calcification-associated polymorphism in HDAC9 and associations with mortality, cardiovascular disease, and kidney disease. iScience 23: 101253, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Fontecha-Barriuso M, Martin-Sanchez D, Ruiz-Andres O, Poveda J, Sanchez-Niño MD, Valiño-Rivas L, : Targeting epigenetic DNA and histone modifications to treat kidney disease. Nephrol Dial Transplant 33: 18751886, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Meijers B, Jouret F, Evenepoel P: Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Pharmacol Res 133: 101107, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Li JY, Yu M, Pal S, Tyagi AM, Dar H, Adams J, : Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota. J Clin Invest 130: 17671781, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, .; DAPA-CKD Trial Committees and Investigators: Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383: 14361446, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    van Bommel EJ, Muskiet MH, Tonneijck L, Kramer MH, Nieuwdorp M, van Raalte DH: SGLT2 inhibition in the diabetic kidney: From mechanisms to clinical outcome. Clin J Am Soc Nephrol 12: 700710, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Moe SM, Drüeke T, Lameire N, Eknoyan G: Chronic kidney disease-mineral-bone disorder: A new paradigm. Adv Chronic Kidney Dis 14: 312, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Moe SM: Renal Osteodystrophy or Kidney-Induced Osteoporosis? Curr Osteoporos Rep 15: 194197, 2017 PubMed

  • 15.

    Wilson LM, Rebholz CM, Jirru E, Liu MC, Zhang A, Gayleard J, : Benefits and harms of osteoporosis medications in patients with chronic kidney disease: A systematic review and meta-analysis. Ann Intern Med 166: 649658, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Bouma-de Krijger A, Vervloet MG: Fibroblast growth factor 23: Are we ready to use it in clinical practice? J Nephrol 33: 509527, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, .; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol 29: 579590, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Jovanovich A, You Z, Isakova T, Nowak K, Cheung A, Wolf M, : Fibroblast growth factor 23 trajectories in chronic hemodialysis patients: Lessons from the HEMO study. Am J Nephrol 49: 263270, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Vervloet M: Renal and extrarenal effects of fibroblast growth factor 23. Nat Rev Nephrol 15: 109120, 2019 PubMed

  • 20.

    Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, : Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: A meta-analysis. J Am Soc Nephrol 29: 20152027, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, : The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Kidney Int 91: 14361446, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Metzinger-Le Meuth V, Burtey S, Maitrias P, Massy ZA, Metzinger L: MicroRNAs in the pathophysiology of CKD-MBD: Biomarkers and innovative drugs. Biochim Biophys Acta Mol Basis Dis 1863: 337345, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, : The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int 93: 147158, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Alfrey AC, Miller NL: Bone magnesium pools in uremia. J Clin Invest 52: 30193027, 1973 PubMed

  • 25.

    de Baaij JH, Hoenderop JG, Bindels RJ: Regulation of magnesium balance: Lessons learned from human genetic disease. Clin Kidney J 5[Suppl 1]: i15i24, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Wyskida K, Witkowicz J, Chudek J, Więcek A: Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease. J Ren Nutr 22: 1926, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Cunningham J, Rodríguez M, Messa P: Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J 5[Suppl 1]: i39i51, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T: Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: A cross-sectional study. PLoS One 10: e0143656, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Castiglioni S, Cazzaniga A, Albisetti W, Maier JA: Magnesium and osteoporosis: Current state of knowledge and future research directions. Nutrients 5: 30223033, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Chang J, Yu D, Ji J, Wang N, Yu S, Yu B: The association between the concentration of serum magnesium and postmenopausal osteoporosis. Front Med (Lausanne) 7: 381, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Huang JH, Cheng FC, Wu HC: Low magnesium exacerbates osteoporosis in chronic kidney disease patients with diabetes. Int J Endocrinol 2015: 380247, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, : Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: What’s changed and why it matters. Kidney Int 92: 2636, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I: Magnesium and risk of hip fracture among patients undergoing hemodialysis. J Am Soc Nephrol 29: 991999, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Covic A, Passlick-Deetjen J, Kroczak M, Büschges-Seraphin B, Ghenu A, Ponce P, : A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: Post hoc evaluation from a controlled, randomized study. Nephrol Dial Transplant 28: 23832392, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35.

    Sahota O, Mundey MK, San P, Godber IM, Hosking DJ: Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17: 10131021, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Vervloet MG: Chronic kidney disease-mineral and bone disorder: Changing insights form changing parameters? Nephrol Dial Transplant 35: 385389, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y: Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 85: 174181, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    de Roij van Zuijdewijn CL, Grooteman MP, Bots ML, Blankestijn PJ, Steppan S, Büchel J, : Serum magnesium and sudden death in European hemodialysis patients. PLoS One 10: e0143104, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, : Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol 21: 49, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y, : Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: A systematic review and meta-analysis. J Nephrol 32: 791802, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Leenders NHJ, Vervloet MG: Magnesium: A magic bullet for cardiovascular disease in chronic kidney disease? Nutrients 11: E455, 2019 PubMed

  • 42.

    Tsuji H, Venditti FJ Jr, Evans JC, Larson MG, Levy D: The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol 74: 232235, 1994 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43.

    Misialek JR, Lopez FL, Lutsey PL, Huxley RR, Peacock JM, Chen LY, : Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans: Atherosclerosis Risk in Communities (ARIC) study. Circ J 77: 323329, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, .; MASTERPLAN Study Group: Abdominal aortic calcification in patients with CKD. J Nephrol 30: 109118, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 17311740, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    Sigrist MK, Taal MW, Bungay P, McIntyre CW: Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2: 12411248, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47.

    Inoue H, Shimizu S, Watanabe K, Kamiyama Y, Shima H, Nakase A, : Impact of trajectories of abdominal aortic calcification over 2 years on subsequent mortality: A 10-year longitudinal study. Nephrol Dial Transplant 33: 676683, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48.

    Vervloet M, Cozzolino M: Vascular calcification in chronic kidney disease: Different bricks in the wall? Kidney Int 91: 808817, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49.

    Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA: Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28: 869878, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50.

    Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF: Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8: 2069, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51.

    Vervloet M: Modifying phosphate toxicity in chronic kidney disease. Toxins (Basel) 11: E522, 2019 PubMed

  • 52.

    Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, : Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23: 17441752, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 53.

    Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, : Calcification propensity and survival among renal transplant recipients. J Am Soc Nephrol 27: 239248, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54.

    Bundy JD, Cai X, Mehta RC, Scialla JJ, de Boer IH, Hsu CY, .; CRIC Study Investigators: Serum calcification propensity and clinical events in CKD. Clin J Am Soc Nephrol 14: 15621571, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55.

    Eelderink C, Te Velde-Keyzer CA, Frenay AS, . Serum calcification propensity and the risk of cardiovascular and all-cause mortality in the general population: The PREVEND study. Arterioscler Thromb Vasc Biol 40:19421951, 2020

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 56.

    Ter Braake AD, Smit AE, Bos C, : Magnesium prevents vascular calcification in Klotho deficiency. Kidney Int 97: 487501, 2020 PubMed

  • 57.

    Joris PJ, Plat J, Bakker SJ, Mensink RP: Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: Results of a randomized, double-blind, placebo-controlled intervention trial. Am J Clin Nutr 103: 12601266, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 58.

    Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, : A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30: 10731085, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 59.

    Leenders NHJ, van Ittersum FJ, Hoekstra T, Hoenderop JGJ, Vervloet MG: Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: A prospective observational cohort study. Sci Rep 8: 10256, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 60.

    Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L: The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: A randomized, controlled clinical trial. Clin J Am Soc Nephrol 13: 13731380, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 61.

    Vervloet MG, van Ballegooijen AJ: Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int 93: 10601072, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 601 601 171
Full Text Views 294 294 115
PDF Downloads 176 176 71